NEW YORK, July 9, 2024 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI).
Shareholders who purchased NARI stock during the stated class period are encouraged to contact the firm regarding a possible appointment as lead plaintiff. Appointment as lead plaintiff is not required to participate in any compensation.
CONTACT US HERE:
SCHOOL LESSON: 10 March 2021 to 28 February 2024
ACCUSATIONS: The complaint alleges that during the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company repeatedly boasted about its financial results and the success of its product sales, but failed to disclose that these figures were inflated by bribes and other improper and illegal payments to healthcare providers; and (2) as a result, Defendants’ positive statements about the Company’s business, operations and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
DEADLINE: 12 July 2024 Shareholders should not hesitate to sign up for this class action lawsuit. Register your information here: https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=89649&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of NARI during the above-mentioned time period, you will be enrolled in portfolio monitoring software that will provide you with status updates throughout the lifecycle of the case. The deadline to apply to be lead plaintiff is July 12, 2024. There is no cost and no obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action litigation firm. Our mission is to protect the rights of all investors who have suffered from deception, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and act as corporate citizens. The firm seeks compensation on behalf of investors who have suffered losses when a company’s false and/or misleading statements or omission of material information have resulted in the artificial inflating of the company’s stock price. Attorney Advertising. Past results do not guarantee similar results.
CONTACT:
The law firm Gross
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903
